A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the P38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
Critical care medicine（2015）
关键词
acute respiratory distress syndrome,clinical trial,p38 mitogen-activated protein kinase,prevention,trauma,treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要